Banerji A - Search Results

1

Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study.

Banerji A, Panzov V, Young M, Robinson J, Lee B, Moraes T, Mamdani M, Giles BL, Jiang D, Bisson D, Dennis M, Morel J, Hall J, Hui C, Paes B, Mahony JB. Banerji A, et al. CMAJ Open. 2016 Oct 17;4(4):E615-E622. doi: 10.9778/cmajo.20150051. eCollection 2016 Oct-Dec. CMAJ Open. 2016. PMID: 28018874 Free PMC article.

2

The cost of lower respiratory tract infections hospital admissions in the Canadian Arctic.

Banerji A, Panzov V, Robinson J, Young M, Ng K, Mamdani M. Banerji A, et al. Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21595. eCollection 2013. Int J Circumpolar Health. 2013. PMID: 23967411 Free PMC article.

3

Cost-effectiveness of palivizumab compared to no prophylaxis in term infants residing in the Canadian Arctic.

Banerji A, Ng K, Moraes TJ, Panzov V, Robinson J, Lee BE. Banerji A, et al. CMAJ Open. 2016 Oct 18;4(4):E623-E633. doi: 10.9778/cmajo.20150052. eCollection 2016 Oct-Dec. CMAJ Open. 2016. PMID: 28443266 Free PMC article.

4

Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children : a case-control study.

Banerji A, Greenberg D, White LF, Macdonald WA, Saxton A, Thomas E, Sage D, Mamdani M, Lanctôt KL, Mahony JB, Dingle M, Roberts A. Banerji A, et al. Pediatr Infect Dis J. 2009 Aug;28(8):697-701. doi: 10.1097/INF.0b013e31819f1f89. Pediatr Infect Dis J. 2009. PMID: 19461554

5

The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic.

Tam DY, Banerji A, Paes BA, Hui C, Tarride JE, Lanctôt KL. Tam DY, et al. Among authors: banerji a. J Med Econ. 2009;12(4):361-70. doi: 10.3111/13696990903442155. J Med Econ. 2009. PMID: 19900071 Free article.

6

Comparison of the cost of hospitalization for respiratory syncytial virus disease versus palivizumab prophylaxis in Canadian Inuit infants.

Banerji A, Lanctôt KL, Paes BA, Masoud ST, Tam DY, Macdonald WA, Roberts A. Banerji A, et al. Pediatr Infect Dis J. 2009 Aug;28(8):702-6. doi: 10.1097/INF.0b013e31819df78e. Pediatr Infect Dis J. 2009. PMID: 19461555

7

The real-life effectiveness of palivizumab for reducing hospital admissions for respiratory syncytial virus in infants residing in Nunavut.

Banerji A, Panzov V, Young M, Lee BE, Mamdani M, Giles BL, Dennis M, Morel J, Bisson D, Paes BA, Hui C, Mahony J. Banerji A, et al. Can Respir J. 2014 May-Jun;21(3):185-9. doi: 10.1155/2014/941367. Epub 2013 Dec 23. Can Respir J. 2014. PMID: 24367792 Free PMC article. Clinical Trial.

8

A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Paes BA, Mitchell I, Banerji A, Lanctôt KL, Langley JM. Paes BA, et al. Among authors: banerji a. Can Respir J. 2011 Mar-Apr;18(2):e10-9. doi: 10.1155/2011/493056. Can Respir J. 2011. PMID: 21499597 Free PMC article.

9

Congenital rubella syndrome despite maternal antibodies.

Banerji A, Ford-Jones EL, Kelly E, Robinson JL. Banerji A, et al. CMAJ. 2005 Jun 21;172(13):1678-9. doi: 10.1503/cmaj.050230. CMAJ. 2005. PMID: 15967967 Free PMC article. No abstract available.

10

High rate of Simkania negevensis among Canadian inuit infants hospitalized with lower respiratory tract infections.

Greenberg D, Banerji A, Friedman MG, Chiu CH, Kahane S. Greenberg D, et al. Among authors: banerji a. Scand J Infect Dis. 2003;35(8):506-8. doi: 10.1080/00365540310014648. Scand J Infect Dis. 2003. PMID: 14514154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters